慢性非癌性疼痛患者对处方阿片类药物使用障碍发展的看法

IF 2.8 3区 医学 Q2 PSYCHIATRY
Lisa E M Davies, Ellen S Koster, Katinka F M Damen, Harmen Beurmanjer, Arnt F A Schellekens, Marcel L Bouvy
{"title":"慢性非癌性疼痛患者对处方阿片类药物使用障碍发展的看法","authors":"Lisa E M Davies,&nbsp;Ellen S Koster,&nbsp;Katinka F M Damen,&nbsp;Harmen Beurmanjer,&nbsp;Arnt F A Schellekens,&nbsp;Marcel L Bouvy","doi":"10.1159/000529926","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In the past decade, prescription opioid use increased exponentially and concomitantly opioid use disorders (OUD) are becoming more common. Several risk factors for developing OUD have been identified, but little is known regarding the patients' perspective on developing a prescription OUD.</p><p><strong>Methods: </strong>We recruited 25 adults undergoing treatment for prescription OUD. In-depth, semi-structured interviews focussed on experiences with long-term opioid use, knowledge and attitudes regarding opioids, and access to opioids. A directed content analysis was conducted on the transcribed interviews using NVivo.</p><p><strong>Results: </strong>Participants showed that the development of an OUD is affected by various factors which could be grouped into three themes: (1) experiences driving initiation, (2) experiences driving continuation, and (3) experiences with prescription OUD. Besides the need for pain management, the dynamics of patient-provider communication, care coordination, provider vigilance, and environmental support all contributed to the way patients used their opioids.</p><p><strong>Conclusion: </strong>Patients' experiences illustrate that the first stage of the development of prescription OUD differs from the development of other substance addictions. Negative reinforcement might play a more prominent role in the early phase of prescription opioid use. Patients expressed a lack of guidance, both at the start of use and long-term use, easy access to new prescriptions and a lack of monitoring as main drivers of the development. Poorly controlled pain and subjective stress fuelled continuous opioid use.</p>","PeriodicalId":11902,"journal":{"name":"European Addiction Research","volume":"29 2","pages":"141-149"},"PeriodicalIF":2.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patients' Perspectives on the Development of Prescription Opioid Use Disorder in Patients with Chronic Non-Cancer Pain.\",\"authors\":\"Lisa E M Davies,&nbsp;Ellen S Koster,&nbsp;Katinka F M Damen,&nbsp;Harmen Beurmanjer,&nbsp;Arnt F A Schellekens,&nbsp;Marcel L Bouvy\",\"doi\":\"10.1159/000529926\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>In the past decade, prescription opioid use increased exponentially and concomitantly opioid use disorders (OUD) are becoming more common. Several risk factors for developing OUD have been identified, but little is known regarding the patients' perspective on developing a prescription OUD.</p><p><strong>Methods: </strong>We recruited 25 adults undergoing treatment for prescription OUD. In-depth, semi-structured interviews focussed on experiences with long-term opioid use, knowledge and attitudes regarding opioids, and access to opioids. A directed content analysis was conducted on the transcribed interviews using NVivo.</p><p><strong>Results: </strong>Participants showed that the development of an OUD is affected by various factors which could be grouped into three themes: (1) experiences driving initiation, (2) experiences driving continuation, and (3) experiences with prescription OUD. Besides the need for pain management, the dynamics of patient-provider communication, care coordination, provider vigilance, and environmental support all contributed to the way patients used their opioids.</p><p><strong>Conclusion: </strong>Patients' experiences illustrate that the first stage of the development of prescription OUD differs from the development of other substance addictions. Negative reinforcement might play a more prominent role in the early phase of prescription opioid use. Patients expressed a lack of guidance, both at the start of use and long-term use, easy access to new prescriptions and a lack of monitoring as main drivers of the development. Poorly controlled pain and subjective stress fuelled continuous opioid use.</p>\",\"PeriodicalId\":11902,\"journal\":{\"name\":\"European Addiction Research\",\"volume\":\"29 2\",\"pages\":\"141-149\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Addiction Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000529926\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Addiction Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000529926","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

在过去的十年中,处方阿片类药物的使用呈指数增长,同时阿片类药物使用障碍(OUD)变得越来越普遍。已经确定了发展OUD的几个危险因素,但对于患者发展处方OUD的观点知之甚少。方法:我们招募了25名正在接受处方OUD治疗的成年人。深入的半结构化访谈侧重于长期使用阿片类药物的经历、关于阿片类药物的知识和态度以及获得阿片类药物的途径。使用NVivo对转录的访谈进行定向内容分析。结果:参与者表明,OUD的发展受多种因素的影响,这些因素可分为三个主题:(1)经历驱动启动,(2)经历驱动持续,(3)经历处方OUD。除了疼痛管理的需要,患者与提供者的沟通、护理协调、提供者警惕和环境支持的动态都有助于患者使用阿片类药物的方式。结论:患者的经历说明处方性OUD发展的第一阶段不同于其他物质成瘾的发展。负强化可能在处方阿片类药物使用的早期阶段发挥更突出的作用。患者表示,在开始使用和长期使用时都缺乏指导,易于获得新处方以及缺乏监测是发展的主要驱动因素。疼痛控制不佳和主观压力加剧了阿片类药物的持续使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Patients' Perspectives on the Development of Prescription Opioid Use Disorder in Patients with Chronic Non-Cancer Pain.

Introduction: In the past decade, prescription opioid use increased exponentially and concomitantly opioid use disorders (OUD) are becoming more common. Several risk factors for developing OUD have been identified, but little is known regarding the patients' perspective on developing a prescription OUD.

Methods: We recruited 25 adults undergoing treatment for prescription OUD. In-depth, semi-structured interviews focussed on experiences with long-term opioid use, knowledge and attitudes regarding opioids, and access to opioids. A directed content analysis was conducted on the transcribed interviews using NVivo.

Results: Participants showed that the development of an OUD is affected by various factors which could be grouped into three themes: (1) experiences driving initiation, (2) experiences driving continuation, and (3) experiences with prescription OUD. Besides the need for pain management, the dynamics of patient-provider communication, care coordination, provider vigilance, and environmental support all contributed to the way patients used their opioids.

Conclusion: Patients' experiences illustrate that the first stage of the development of prescription OUD differs from the development of other substance addictions. Negative reinforcement might play a more prominent role in the early phase of prescription opioid use. Patients expressed a lack of guidance, both at the start of use and long-term use, easy access to new prescriptions and a lack of monitoring as main drivers of the development. Poorly controlled pain and subjective stress fuelled continuous opioid use.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Addiction Research
European Addiction Research SUBSTANCE ABUSE-PSYCHIATRY
CiteScore
6.80
自引率
5.10%
发文量
32
审稿时长
>12 weeks
期刊介绍: ''European Addiction Research'' is a unique international scientific journal for the rapid publication of innovative research covering all aspects of addiction and related disorders. Representing an interdisciplinary forum for the exchange of recent data and expert opinion, it reflects the importance of a comprehensive approach to resolve the problems of substance abuse and addiction in Europe. Coverage ranges from clinical and research advances in the fields of psychiatry, biology, pharmacology and epidemiology to social, and legal implications of policy decisions. The goal is to facilitate open discussion among those interested in the scientific and clinical aspects of prevention, diagnosis and therapy as well as dealing with legal issues. An excellent range of original papers makes ‘European Addiction Research’ the forum of choice for all.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信